3D Systems Expands Industrial and Healthcare 3D Printing Capabilities with Strategic Acquisitions of Titan Robotics and Kumovis

The additive manufacturing (AM) industry continues its dynamic trajectory of innovation and expansion, even in the early months of the year. Following a series of significant announcements from various sector leaders, a major development has emerged from one of the pioneering forces in 3D printing. 3D Systems, renowned as one of the original 3D printer manufacturers and the inventor of the foundational SLA (Stereolithography) technology, has announced a strategic expansion through two key acquisitions: Titan Additive LLC (operating as Titan Robotics) and Kumovis. This dual acquisition marks a pivotal moment for 3D Systems, signaling not only a robust re-entry into the extrusion 3D printing market but also a profound strengthening of its foothold in the healthcare sector, particularly in the production of advanced 3D printed medical devices utilizing high-performance polymers like PEEK.

The previous year witnessed an unprecedented surge in mergers and acquisitions across the 3D printing landscape. Interestingly, 3D Systems adopted a different strategy, choosing instead to divest several non-core business units. This seemingly counter-intuitive move was, in fact, a carefully orchestrated part of the company’s long-term vision: to sharpen its focus and channel resources predominantly towards developing industrial-scale additive manufacturing solutions. The latest acquisitions emphatically underscore this strategic shift, suggesting a renewed emphasis on targeted growth. This recent activity prompts a crucial question for industry observers: is 3D Systems, after a period of strategic divestment, officially back in an aggressive acquisition mode, poised to reclaim and expand its market leadership?

A Strategic Re-entry into Extrusion Technologies with Titan Robotics

While 3D Systems previously engaged with extrusion solutions through its acquisition of Cubify in 2012, its FDM (Fused Deposition Modeling) printers are no longer part of its active portfolio. The acquisitions of both Titan Robotics and Kumovis now signify a deliberate and strategic return for 3D Systems into the realm of extrusion-based additive manufacturing. Titan Robotics, in particular, stands out due to its established reputation as a leading manufacturer of large-format, industrial 3D printers that utilize pellet-based extrusion. This technology is a significant differentiator, offering distinct advantages over traditional filament-based systems.

Pellet 3D printing has steadily gained significant traction and popularity within the additive manufacturing sector. This rise is primarily attributed to its numerous benefits, including significantly lower material costs due to the use of readily available thermoplastic pellets (which are often cheaper than filaments) and a much wider array of compatible materials. This material flexibility extends to engineering-grade and high-performance polymers that are difficult or impossible to process with traditional filament extruders. Dr. Jeffrey Graves, President and CEO of 3D Systems, articulated the strategic value of the Titan acquisition: “With the addition of Titan Robotics’ unique extrusion technology, we will be able to address our customers’ need for large build volumes, superior performance, and improved productivity at a significantly lower cost. Through the innovative modular approach of their printers, and the ability to use both pellet and filament product forms in an open architecture with widely available production polymer systems, we believe the adoption rate of industrial 3D printing will continue to accelerate.” This statement highlights the core advantages: cost efficiency, high performance, and an open materials platform, all critical factors for broader industrial adoption.

A distinctive feature of Titan Robotics, as highlighted in the press release, is its position as the sole manufacturer currently offering hybrid tool head configurations. These advanced systems seamlessly integrate pellet extrusion, filament extrusion, and even a spindle tool head for precision finishing operations within a single machine. This multi-process capability dramatically enhances the versatility of their printers, allowing for complex geometries, multi-material components, and post-processing directly on the platform. Furthermore, Titan’s printers boast impressive build chambers, ranging from substantial sizes like 30” x 30” x 45” up to massive capacities of 50” x 50” x 72”. Coupled with rapid print speeds of up to 30,000 mm per minute, these specifications cater directly to the demands of large-scale industrial manufacturing. Given 3D Systems’ existing commitment to industrial printing through its advanced SLA and SLS technologies, the integration of Titan Robotics’ industrial extrusion capabilities creates a truly comprehensive portfolio. This strategic addition not only broadens 3D Systems’ technological offerings but also significantly expands its material options by introducing the economic and performance benefits of pellet 3D printing, enabling customers to leverage a wider range of polymers for diverse industrial applications.

Expanding 3D Systems’ Healthcare Portfolio with Kumovis

The acquisition of Kumovis concurrently enhances 3D Systems’ extrusion capabilities, albeit with a highly specialized focus. Kumovis, a pioneering startup, has garnered attention for its innovative technology enabling the precise creation of medical parts, particularly leveraging high-performance polymers like PEEK. For 3D Systems, this acquisition provides direct access to cutting-edge extrusion printing technology specifically tailored for medical-grade polymers, a critical advancement in their healthcare strategy. Furthermore, 3D Systems anticipates achieving regulatory clearance for Kumovis’ machines, an essential step that will significantly accelerate their growth and market penetration in the highly regulated medical device sector.

The strategic importance of using PEEK and other similar biocompatible, high-performance materials in medical applications cannot be overstated. PEEK is frequently the material of choice for human implants and surgical instrumentation due to its exceptional properties. These include excellent biocompatibility, high mechanical strength comparable to bone, chemical inertness, sterilizability, and radiolucency (meaning it is transparent to X-rays, allowing for clearer post-operative imaging). Given the burgeoning importance of 3D printing in creating highly customized implants and patient-specific surgical guides for the medical field, it is evident that 3D Systems aims to significantly advance its expertise and offerings in this critical application area. The company specifically notes its intention to expand its offerings in craniomaxillofacial applications, which will integrate their existing virtual surgical planning (VSP) solutions. This expansion will also include the creation of specialized bone plates for trauma, fostering growth in the trauma segment of the healthcare market, and further strengthening their leading position in the production of spinal cages, where 3D Systems is already a recognized leader.

Dr. Graves further elaborated on the synergies with Kumovis, stating, “Our proven ability to deliver regulatory-approved, implantable 3D printed medical devices, personalized to improve patient outcomes, to surgeons around the world through our exceptional channel partners, will help ensure that the Kumovis PEEK-based offerings can be brought to market quickly and effectively. Moreover, 3D Systems’ expanding point of care initiatives will be greatly enhanced through the inclusion of Kumovis’ unique ‘integrated clean room’ printing technology, allowing hospitals and other end-users to tailor products on-demand, to meet specific patient requirements in the quickest and most resource-efficient manner.” This integrated clean room technology is a significant innovation, enabling compliant and sterile manufacturing directly within healthcare facilities, revolutionizing point-of-care production by allowing for immediate, customized solutions. These acquisitions represent a formidable expansion of 3D Systems’ capabilities across both the industrial and healthcare sectors, reinforcing their commitment to driving innovation and adoption of advanced additive manufacturing technologies. Comprehensive details regarding both acquisitions can be found in the press releases issued by 3D Systems, accessible HERE for Kumovis and HERE for Titan Additive.

What are your thoughts on 3D Systems’ latest strategic acquisitions? Do you foresee even greater consolidation and accelerated innovation within the 3D printing sector throughout 2022 and beyond? Share your insights in a comment below or connect with us on our LinkedIn, Facebook, and Twitter pages! Don’t forget to subscribe to our free weekly Newsletter here to receive the latest 3D printing news directly to your inbox. You can also explore all our insightful videos on our YouTube channel.

*Cover Photo Credits: Titan Robotics